An 8-year-old boy is repeatedly in trouble at school. He has been threatened with suspension after he was verbally and physically aggressive to his teacher. The school has suggested that he has a problem with his concentration and advised his parents to seek help. The school also referred him to the school child psychologist. He keeps wriggling in his seat. His mother says his concentration is fine when he is playing on his computer. What worries her is that he does not seem to think before he does things and will run out across the road without looking.
Summarize the clinical case.
What is the DSM 5-TR diagnosis based on the information provided in the case?
Which pharmacological treatment would you prescribe according to the clinical guidelines? Include the rationale for this treatment.
Which non-pharmacological treatment would you prescribe according to the clinical guidelines? Include the rationale for this treatment excluding a psychotherapeutic modality.
Include an assessment of the treatment’s appropriateness, cost, effectiveness, safety, and potential for patient adherence to the chosen medication. Use a local pharmacy to research the cost of the medication and provide the most cost-effective choice for the patient. Use great detail when answering questions 3-5.
Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic source
An 8-year-old boy is exhibiting behavioral difficulties at school, characterized by aggression, difficulty concentrating, and impulsivity. His mother reports similar behaviors at home, including difficulty focusing and impulsive actions, such as running into the street without looking. The boy’s academic performance is likely to be affected due to his inability to concentrate.
Based on the provided information, the boy’s symptoms align with the diagnostic criteria for Attention-Deficit/Hyperactivity Disorder (ADHD), predominantly inattentive presentation. This diagnosis is supported by the child’s difficulties with concentration, impulsivity (as evidenced by running into the street without looking), and hyperactivity (manifested as fidgeting in his seat).
Methylphenidate (Ritalin) is a commonly used first-line medication for ADHD. It is a stimulant that improves attention, reduces impulsivity, and hyperactivity. The American Academy of Pediatrics (AAP) recommends stimulant medications as first-line treatment for ADHD in children (American Academy of Pediatrics, 2011).
Rationale: Methylphenidate has demonstrated efficacy in addressing the core symptoms of ADHD, including inattention, hyperactivity, and impulsivity. It is well-tolerated in most children and has a proven safety profile.
Behavioral Therapy: A behavior modification program can be highly effective in managing ADHD symptoms. This involves implementing consistent rules, rewards, and consequences at home and school. Parent training and education are also crucial components of behavioral therapy.
Rationale: Behavioral therapy addresses the underlying behavioral challenges associated with ADHD. By teaching parents and teachers effective behavior management strategies, it can improve the child’s functioning at home and school.
Methylphenidate (Ritalin):
Behavioral Therapy:
The child in this case presents with symptoms consistent with ADHD, predominantly inattentive type. A combination of medication and behavioral therapy is recommended for optimal management. Methylphenidate is a suitable first-line pharmacological treatment, and behavior modification strat